Abstract

The specific aims of the investigators involved in this project are to contribute to, and participate in, the scientific and clinical research activities of the Southeastern Cancer Study Group.
The aims i nclude entering as many patients as possible on Group protocol studies, expanding and improving involvement of all disciplines in the scientific and clinical research activities, and to explore new areas for research and treatment.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
3U10CA003227-29S1
Application #
3555740
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1977-08-01
Project End
1987-07-31
Budget Start
1985-08-01
Budget End
1987-07-31
Support Year
29
Fiscal Year
1986
Total Cost
Indirect Cost

  Institution

Name
Emory University
Department
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322

  Publications

Vogler, W R; Velez-Garcia, E; Weiner, R S et al. (1992) A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study. J Clin Oncol 10:1103-11
Lazarus, H M; Vogler, W R; Burns, C P et al. (1989) High-dose cytosine arabinoside and daunorubicin as primary therapy in elderly patients with acute myelogenous leukemia. A phase I-II study of the Southeastern Cancer Study Group. Cancer 63:1055-9
Vogler, W R; Raney, M R (1988) Prognostic significance of blood and marrow findings in acute myelogenous leukemia in remission. A Southeastern Cancer Study Group report. Cancer 61:2481-6
Walther, P J; Williams, S D; Troner, M et al. (1986) Phase II study of etoposide for carcinoma of the bladder: the Southeastern Cancer Study Group experience. Cancer Treat Rep 70:1337-8
Moore, M R; Troner, M B; DeSimone, P et al. (1986) Phase II evaluation of weekly cisplatin in metastatic hormone-resistant prostate cancer: a Southeastern Cancer Study Group Trial. Cancer Treat Rep 70:541-2
Carpenter Jr, J T; Vogel, C L; Wang, G et al. (1986) Phase II evaluation of fludarabine in patients with metastatic breast cancer: a Southeastern Cancer Study Group trial. Cancer Treat Rep 70:1235-6
Walther, P J; Williams, S D; Troner, M et al. (1986) Phase II study of etoposide for carcinoma of the prostate. Cancer Treat Rep 70:771-2
Wolff, S N; Birch, R; Sarma, P et al. (1986) Randomized dose-response evaluation of etoposide in small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial. Cancer Treat Rep 70:583-7
Gockerman, J P; Spremulli, E N; Raney, M et al. (1986) Randomized comparison of tamoxifen versus diethylstilbestrol in estrogen receptor-positive or -unknown metastatic breast cancer: a Southeastern Cancer Study Group trial. Cancer Treat Rep 70:1199-203
Ravry, M J; Moore, M R; Omura, G A et al. (1985) Phase II evaluation of cisplatin in squamous carcinoma of the esophagus: a Southeastern Cancer Study Group trial. Cancer Treat Rep 69:1457-8